N2 extenuates experimental ischemic stroke through platelet aggregation inhibition

Thrombosis Research

Volumn 136, Issue 6, 2015, Pages 1310-1317

  Yang, Lijian ^a   Chen, Xi ^a   Wang, Siqi ^a   Fei, Yuxiang ^a   Wang, Ding ^a   Li, Yunman ^a   He, Guangwei ^b   Wu, Qiang ^b   Chu, Shaoxing ^b   Fang, Weirong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Hefei Yigong Medicine Co Ltd   (China)

Author keywords

Ischemic stroke; N2; Platelet aggregation; Thromboxane A2

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 4 [2 (1H IMIDAZOL 1 YL)ETHOXY] 3 METHOXYBENZOIC ACID; 6 OXOPROSTAGLANDIN F1 ALPHA; ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; OZAGREL; THROMBOXANE A2; UNCLASSIFIED DRUG; 4-(2-(1H-IMIDAZOL-1-YL)ETHOXY)-3-METHOXYBENZOIC ACID; DAZOXIBEN; IMIDAZOLE DERIVATIVE; PROSTACYCLIN; VANILLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING TIME; BLOOD CLOTTING TIME; BRAIN EDEMA; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG MEGADOSE; EXPERIMENTAL LOCOMOTOR ACTIVITY TEST; FEMALE; LIMB USE ASYMMETRY TEST; LOW DRUG DOSE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION REPERFUSION; MORRIS WATER MAZE TEST; MOTOR PERFORMANCE; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NONHUMAN; POSTURAL REFLEX TEST; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; WATER CONTENT; ANALOGS AND DERIVATIVES; ANIMAL; ARTERIOVENOUS SHUNT; BLOOD CLOTTING; BRAIN; CHEMISTRY; DRUG EFFECTS; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; MAZE TEST; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; STROKE; THROMBOSIS;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADENOSINE DIPHOSPHATE; ANIMALS; ARTERIOVENOUS SHUNT, SURGICAL; BLOOD COAGULATION; BRAIN; BRAIN ISCHEMIA; EDEMA; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPOPROSTENOL; FEMALE; IMIDAZOLES; MALE; MAZE LEARNING; PLATELET AGGREGATION; RATS; RATS, SPRAGUE-DAWLEY; STROKE; THROMBOSIS; THROMBOXANE A2; VANILLIC ACID;

EID: 84949190402     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2015.10.039     Document Type: Article

References (34)

1. G.A. Donnan, M. Fisher, M. Macleod, and S.M. Davis Stroke Lancet 371 2008 1612 1623
2. A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, M.J. Blaha, and et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association Circulation 129 2014 e28 e292
3. Ph.D K. Göran, and M.D. Hansson Inflammation, atherosclerosis, and coronary artery disease N. Engl. J. Med. 352 2005 1685 1695
4. M.S.A. Sakthivel Vaiyapuri, L.A. Moraes, T. Sage, K.R. Lewis, C.I. Jones, and J.M. Gibbins Tangeretin regulates platelet function through inhibition of phosphoinositide 3-kinase and cyclic nucleotide signaling Arterioscler. Thromb. Vasc. Biol. 33 2013 2740 2749
5. Chair G.W. Albers M, M.D. Pierre Amarenco, J. Donald Easton MRLS, MD, and M. Philip Teal Antithrombotic and thrombolytic therapy for ischemic stroke.The Seventh ACCP conference on antithrombotic and thrombolytic therapy Chest 126 2004 483S 512S
6. N.E. Barrett, L. Holbrook, S. Jones, W.J. Kaiser, L.A. Moraes, R. Rana, and et al. Future innovations in anti-platelet therapies Br. J. Pharmacol. 154 2008 918 939
7. Q.E. Fuentes, Q.F. Fuentes, V. Andres, O.M. Pello, J. Font de Mora, and G.I. Palomo Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis Platelets 24 2013 255 262
8. J.E. Burke, and E.A. Dennis Phospholipase A2 biochemistry Cardiovasc. Drugs Ther. 23 2009 49 59
9. F. Swieringa, M.J. Kuijpers, J.W. Heemskerk, and P.E. van der Meijden Targeting platelet receptor function in thrombus formation: the risk of bleeding Blood Rev. 28 2014 9 21
10. E.Z. Longa, P.R. Weinstein, S. Carlson, and R. Cummins Reversible middle cerebral artery occlusion without craniectomy in rats Stroke 20 1989 84 91
11. R. Morris Developments of a water-maze procedure for studying spatial learning in the rat J. Neurosci. Methods 11 1984 47 60
12. Y.K. Baskin, W.D. Dietrich, and E.J. Green Two effective behavioral tasks for evaluating sensorimotor dysfunction following traumatic brain injury in mice J. Neurosci. Methods 129 2003 87 93
13. S. Zausinger, E. Hungerhuber, A. Baethmann, H.J. Reulen, and R. Schmid-Elsaesser Neurological impairment in rats after transient middle cerebral artery occlusion: a comparative study under various treatment paradigms Brain Res. 863 2000 94 105
14. D.M. Senda, S. Franzin, M.A. Mori, R.M. de Oliveira, and H. Milani Acute, post-ischemic sensorimotor deficits correlate positively with infarct size but fail to predict its occurrence and magnitude after middle cerebral artery occlusion in rats Behav. Brain Res. 216 2011 29 35
15. S.S. Raza, M.M. Khan, A. Ahmad, M. Ashafaq, F. Islam, A.P. Wagner, and et al. Neuroprotective effect of naringenin is mediated through suppression of NF-kappaB signaling pathway in experimental stroke Neuroscience 230 2013 157 171
16. J.T.H. Shizuo Hatashita, and S.M. Salamat Ischemic brain edema and the osmotic gradient between blood and brain J. Cereb. Blood Flow Metab. 8 1988 552 559
17. H. Ji, S.P. Li, X. Cheng, H.R. Cheng, T.B. Ng, P. Li, and et al. Antithrombotic effects of low-molecular-weight heparin calcium (LMWH-Ca) in experimental models Gen. Pharmacol. 33 1999 207 211
18. H. Nobukata, T. Ishikawa, M. Obata, and Y. Shibutani Age-related changes in coagulation, fibrinolysis, and platelet aggregation in male WBN/Kob rats Thromb. Res. 98 2000 507 516
19. J. Huang, S. Wang, X. Luo, Y. Xie, and X. Shi Cinnamaldehyde reduction of platelet aggregation and thrombosis in rodents Thromb. Res. 119 2007 337 342
20. E. Dejana, A. Callioni, A. Quintana, and G. de Gaetano Bleeding time in laboratory animals. II - a comparison of different assay conditions in rats Thromb. Res. 15 1979 191 197
21. J. Bogousslavsky Topographic patterns of cerebral infarcts Cerebrovasc. Dis. 1 Suppl. 1 1991 61 68
22. G. Rordorf, W.J. Koroshetz, W.A. Copen, S.C. Cramer, P.W. Schaefer, R.F. Budzik, and et al. Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted MRI Stroke 29 1998 939 943
23. A. Moretti, F. Ferrari, and R.F. Villa Neuroprotection for ischaemic stroke: current status and challenges Pharmacol. Ther. 2014
24. S. Warach, and L.L. Latour Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption Stroke 35 2004 2659 2661
25. F. Liu, and L.D. McCullough Middle cerebral artery occlusion model in rodents: methods and potential pitfalls J. Biomed. Biotechnol. 2011 2011 464701
26. S.T. Chen, C.Y. Hsu, E.L. Hogan, H. Maricq, and J.D. Balentine A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction Stroke 17 1986 738 743
27. L. Tanya, C.A.K. Butler, P.R. Sanberg, A.E. Willing, and K.R. Pennypacker∗ Neurodegeneration in the rat hippocampus and striatum after middle cerebral artery occlusion Brain Res. 929 2002 252 260
28. D.L. Bhatt, and E.J. Topol Scientific and therapeutic advances in antiplatelet therapy Nat. Rev. Drug Discov. 2 2003 15 28
29. S.P. Jackson The growing complexity of platelet aggregation Blood 109 2007 5087 5095
30. J. Pan, A.A. Konstas, B. Bateman, G.A. Ortolano, and J. Pile-Spellman Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies Neuroradiology 49 2007 93 102
31. D.G. Sherman Prevention of venous thromboembolism, recurrent stroke, and other vascular events after acute ischemic stroke: the role of low-molecular-weight heparin and antiplatelet therapy J. Stroke Cerebrovasc. Dis. 15 2006 250 259
32. L.A. Harker Therapeutic inhibition of platelet function in stroke Cerebrovasc. Dis. 8 Suppl. 5 1998 8 18
33. Y. Matsuo, M. Izumiyama, H. Onodera, A. Kurosawa, and K. Kogure Effect of a novel thromboxane A2 receptor antagonist, S-1452, on postischemic brain injury in rats Stroke 24 1993 2059 2064
34. S.E. Lind The bleeding time does not predict surgical bleeding Blood 77 1991 2547 2552